Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polycystic kidney disease
Carsten Bergmann, Lisa M. Guay‐Woodford, Peter C. Harris, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 600

Showing 26-50 of 600 citing articles:

Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—a randomized controlled trial
Sadrija Cukoski, Christoph Heinrich Lindemann, Sita Arjune, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101283-101283
Open Access | Times Cited: 38
A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases
Francesca Becherucci, Samuela Landini, Viviana Palazzo, et al.
Journal of the American Society of Nephrology (2023) Vol. 34, Iss. 4, pp. 706-720
Closed Access | Times Cited: 33
TRPM channels in health and disease
Vladimir Chubanov, Michael Köttgen, Rhian M. Touyz, et al.
Nature Reviews Nephrology (2023) Vol. 20, Iss. 3, pp. 175-187
Closed Access | Times Cited: 31
Polycystin Channel Complexes
Orhi Esarte Palomero, Megan Larmore, Paul G. DeCaen
Annual Review of Physiology (2023) Vol. 85, Iss. 1, pp. 425-448
Open Access | Times Cited: 29
A comprehensive review on 3D tissue models: Biofabrication technologies and preclinical applications
Renjian Xie, Vaibhav Pal, Yanrong Yu, et al.
Biomaterials (2023) Vol. 304, pp. 122408-122408
Closed Access | Times Cited: 25
Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease
Biao Huang, Zipeng Zeng, Sung‐Hyun Kim, et al.
Cell stem cell (2024) Vol. 31, Iss. 6, pp. 921-939.e17
Closed Access | Times Cited: 11
Structural basis of tolvaptan binding to the vasopressin V2 receptor
Hongli Liu, Haiyang Zhong, Yixiao Zhang, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 11, pp. 2441-2449
Closed Access | Times Cited: 11
A new era in the science and care of kidney diseases
Carmine Zoccali, Francesca Mallamaci, Liz Lightstone, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 7, pp. 460-472
Closed Access | Times Cited: 10
Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
Matthew Gittus, Helen Haley, Tess Harris, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease
Daniyal J. Jafree, Dale Moulding, Maria Kolatsi‐Joannou, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 61
Ferroptosis Promotes Cyst Growth in Autosomal Dominant Polycystic Kidney Disease Mouse Models
Xiaoqin Zhang, Xiaoyan Li, Hao Ding, et al.
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 11, pp. 2759-2776
Open Access | Times Cited: 56
Ferroptosis and kidney diseases
Shumei Tang, Xiangcheng Xiao
International Urology and Nephrology (2019) Vol. 52, Iss. 3, pp. 497-503
Closed Access | Times Cited: 55
SGLT2 inhibition requires reconsideration of fundamental paradigms in chronic kidney disease, ‘diabetic nephropathy’, IgA nephropathy and podocytopathies with FSGS lesions
Hans‐Joachim Anders, Anna Julie Peired, Paola Romagnani
Nephrology Dialysis Transplantation (2020) Vol. 37, Iss. 9, pp. 1609-1615
Open Access | Times Cited: 52
The lymphatics in kidney health and disease
Michael D. Donnan, Yael Kenig-Kozlovsky, Susan E. Quaggin
Nature Reviews Nephrology (2021) Vol. 17, Iss. 10, pp. 655-675
Open Access | Times Cited: 50
Computer-aided diagnosis system for the classification of multi-class kidney abnormalities in the noisy ultrasound images
S Sudharson, Priyanka Kokil
Computer Methods and Programs in Biomedicine (2021) Vol. 205, pp. 106071-106071
Closed Access | Times Cited: 48
The Biology of Vasopressin
Samantha Sparapani, Cassandra Millet-Boureima, Joshua Oliver, et al.
Biomedicines (2021) Vol. 9, Iss. 1, pp. 89-89
Open Access | Times Cited: 45
In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
Kun Huang, Daniel Zapata, Yan Tang, et al.
Biomaterials (2022) Vol. 291, pp. 121876-121876
Open Access | Times Cited: 33
Lifestyle-Related Risk Factors for the Incidence and Progression of Chronic Kidney Disease in the Healthy Young and Middle-Aged Population
Akihiro Kuma, Akihiko Kato
Nutrients (2022) Vol. 14, Iss. 18, pp. 3787-3787
Open Access | Times Cited: 30
Role of Sex Hormones in Prevalent Kidney Diseases
Carolina Conte, Giulia Antonelli, Maria Elena Melica, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8244-8244
Open Access | Times Cited: 22
Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease
Hamad Ali, Md. Zubbair Malik, Mohamed Abu‐Farha, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 2
Open Access | Times Cited: 8
Biomarkers of Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease
Ahmad Ghanem, Abdul Hamid Borghol, Fadi George Munairdjy Debeh, et al.
Kidney International Reports (2024) Vol. 9, Iss. 10, pp. 2860-2882
Open Access | Times Cited: 8
Regulation of ciliary homeostasis by intraflagellar transport-independent kinesins
Lin Li, Jie Ran
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Deliverables from Metabolomics in Kidney Disease: Adenine, New Insights, and Implication for Clinical Decision-Making
Nagarjunachary Ragi, Kumar Sharma
American Journal of Nephrology (2024) Vol. 55, Iss. 4, pp. 421-438
Open Access | Times Cited: 6
Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression
Sara Clerici, Christine Podrini, Davide Stefanoni, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 6, pp. 1379-1403
Open Access | Times Cited: 6
MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer
Ramazan Gündoğdu, Alexander Hergovich
Cells (2019) Vol. 8, Iss. 6, pp. 569-569
Open Access | Times Cited: 48

Scroll to top